In particular, cisplatin and 5-FU trigger the downregulation of the antiapoptotic proteins cFLIP and the upregulation of TRAIL-R1 and TRAIL-R2 receptors and may efficiently sensitize HCC cells, but not normal hepatocytes to TRAIL-induced apoptosis [28,60]. This evidence concerns the gene CFLAR and hepatocellular carcinoma.